Compare Stocks

5 / 10
Try these comparisons:

Stock Comparison

IINN vs DBVT vs AVAV vs ALKS vs INVA

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
IINN
Inspira Technologies Oxy B.H.N. Ltd.

Medical - Devices

HealthcareNASDAQ • IL
Market Cap$11M
5Y Perf.-88.5%
DBVT
DBV Technologies S.A.

Biotechnology

HealthcareNASDAQ • FR
Market Cap$1712.35T
5Y Perf.-61.6%
AVAV
AeroVironment, Inc.

Aerospace & Defense

IndustrialsNASDAQ • US
Market Cap$8.40B
5Y Perf.+66.4%
ALKS
Alkermes plc

Biotechnology

HealthcareNASDAQ • IE
Market Cap$5.90B
5Y Perf.+36.8%
INVA
Innoviva, Inc.

Biotechnology

HealthcareNASDAQ • US
Market Cap$1.93B
5Y Perf.+60.8%

IINN vs DBVT vs AVAV vs ALKS vs INVA — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
IINN logoIINN
DBVT logoDBVT
AVAV logoAVAV
ALKS logoALKS
INVA logoINVA
IndustryMedical - DevicesBiotechnologyAerospace & DefenseBiotechnologyBiotechnology
Market Cap$11M$1712.35T$8.40B$5.90B$1.93B
Revenue (TTM)$289K$0.00$1.61B$1.56B$424M
Net Income (TTM)$-13M$-168M$-224M$153M$504M
Gross Margin0.7%21.8%65.4%76.2%
Operating Margin45.1%-8.3%12.3%14.8%
Forward P/E58.4x24.8x11.9x
Total Debt$3M$22M$64M$70M$269M
Cash & Equiv.$5M$194M$41M$1.12B$551M

IINN vs DBVT vs AVAV vs ALKS vs INVALong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

IINN
DBVT
AVAV
ALKS
INVA
StockJul 21May 26Return
Inspira Technologie… (IINN)10011.5-88.5%
DBV Technologies S.… (DBVT)10038.4-61.6%
AeroVironment, Inc. (AVAV)100166.4+66.4%
Alkermes plc (ALKS)100136.8+36.8%
Innoviva, Inc. (INVA)100160.8+60.8%

Price return only. Dividends and distributions are not included.

Quick Verdict: IINN vs DBVT vs AVAV vs ALKS vs INVA

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: INVA leads in 5 of 7 categories (5-stock set), making it the strongest pick for growth and revenue expansion and valuation and capital efficiency. DBV Technologies S.A. is the stronger pick specifically for recent price momentum and sentiment. This set spans 2 sectors — these stocks serve different portfolio roles, not just different price points.
IINN
Inspira Technologies Oxy B.H.N. Ltd.
The Healthcare Pick

IINN plays a supporting role in this comparison — it may shine differently against other peers.

Best for: healthcare exposure
DBVT
DBV Technologies S.A.
The Income Pick

DBVT is the #2 pick in this set and the best alternative if income & stability is your priority.

  • Dividend streak 0 yrs, beta 1.26
  • +110.4% vs IINN's -16.3%
Best for: income & stability
AVAV
AeroVironment, Inc.
The Industrials Pick

AVAV lags the leaders in this set but could rank higher in a more targeted comparison.

Best for: industrials exposure
ALKS
Alkermes plc
The Quality Angle

Among these 5 stocks, ALKS doesn't own a clear edge in any measured category.

Best for: healthcare exposure
INVA
Innoviva, Inc.
The Growth Play

INVA carries the broadest edge in this set and is the clearest fit for growth exposure and long-term compounding.

  • Rev growth 18.5%, EPS growth 8.2%, 3Y rev CAGR 8.7%
  • 94.9% 10Y total return vs AVAV's 498.3%
  • Lower volatility, beta 0.13, Low D/E 22.9%, current ratio 14.64x
  • Beta 0.13, current ratio 14.64x
Best for: growth exposure and long-term compounding
See the full category breakdown
CategoryWinnerWhy
GrowthINVA logoINVA18.5% revenue growth vs DBVT's -100.0%
ValueINVA logoINVALower P/E (11.9x vs 24.8x)
Quality / MarginsINVA logoINVA118.9% margin vs IINN's -43.7%
Stability / SafetyINVA logoINVABeta 0.13 vs AVAV's 1.57
DividendsTieNone of these 5 stocks pay a meaningful dividend
Momentum (1Y)DBVT logoDBVT+110.4% vs IINN's -16.3%
Efficiency (ROA)INVA logoINVA32.4% ROA vs IINN's -275.8%, ROIC 14.2% vs 0.5%

IINN vs DBVT vs AVAV vs ALKS vs INVA — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

IINNInspira Technologies Oxy B.H.N. Ltd.

Segment breakdown not available.

DBVTDBV Technologies S.A.

Segment breakdown not available.

AVAVAeroVironment, Inc.
FY 2024
Product sales
81.7%$586M
Contract services
18.3%$131M
ALKSAlkermes plc
FY 2025
Vivitrol
39.8%$468M
Aristada And Aristada Initio
31.5%$370M
Manufactured Product And Royalty
24.8%$291M
Manufacturing Revenue
3.9%$46M
INVAInnoviva, Inc.
FY 2025
Royalty
57.5%$236M
Product
41.8%$172M
License And Other Revenue
0.7%$3M

IINN vs DBVT vs AVAV vs ALKS vs INVA — Financial Metrics

Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLINVALAGGINGAVAV

Income & Cash Flow (Last 12 Months)

INVA leads this category, winning 4 of 6 comparable metrics.

AVAV and DBVT operate at a comparable scale, with $1.6B and $0 in trailing revenue. INVA is the more profitable business, keeping 118.9% of every revenue dollar as net income compared to IINN's -43.7%. On growth, AVAV holds the edge at +143.4% YoY revenue growth, suggesting stronger near-term business momentum.

MetricIINN logoIINNInspira Technolog…DBVT logoDBVTDBV Technologies …AVAV logoAVAVAeroVironment, In…ALKS logoALKSAlkermes plcINVA logoINVAInnoviva, Inc.
RevenueTrailing 12 months$289,000$0$1.6B$1.6B$424M
EBITDAEarnings before interest/tax$13M-$112M$82M$212M$86M
Net IncomeAfter-tax profit-$13M-$168M-$224M$153M$504M
Free Cash FlowCash after capex$0-$151M-$183M$392M$181M
Gross MarginGross profit ÷ Revenue+0.7%+21.8%+65.4%+76.2%
Operating MarginEBIT ÷ Revenue+45.1%-8.3%+12.3%+14.8%
Net MarginNet income ÷ Revenue-43.7%-13.9%+9.8%+118.9%
FCF MarginFCF ÷ Revenue-11.3%+25.1%+42.8%
Rev. Growth (YoY)Latest quarter vs prior year+143.4%+28.2%+10.6%
EPS Growth (YoY)Latest quarter vs prior year+36.8%+91.5%-51.5%-4.1%+4.0%
INVA leads this category, winning 4 of 6 comparable metrics.

Valuation Metrics

INVA leads this category, winning 3 of 6 comparable metrics.

At 6.9x trailing earnings, INVA trades at a 94% valuation discount to AVAV's 108.5x P/E. On an enterprise value basis, INVA's 8.1x EV/EBITDA is more attractive than IINN's 726.5x.

MetricIINN logoIINNInspira Technolog…DBVT logoDBVTDBV Technologies …AVAV logoAVAVAeroVironment, In…ALKS logoALKSAlkermes plcINVA logoINVAInnoviva, Inc.
Market CapShares × price$11M$1712.35T$8.4B$5.9B$1.9B
Enterprise ValueMkt cap + debt − cash$8M$1712.35T$8.4B$4.9B$1.7B
Trailing P/EPrice ÷ TTM EPS-750.00x-0.76x108.50x24.76x6.91x
Forward P/EPrice ÷ next-FY EPS est.58.41x11.91x
PEG RatioP/E ÷ EPS growth rate0.67x
EV / EBITDAEnterprise value multiple726.48x102.96x17.25x8.10x
Price / SalesMarket cap ÷ Revenue10.23x4.00x4.55x
Price / BookPrice ÷ Book value/share1.93x0.66x5.34x3.28x1.65x
Price / FCFMarket cap ÷ FCF12.28x9.88x
INVA leads this category, winning 3 of 6 comparable metrics.

Profitability & Efficiency

ALKS leads this category, winning 5 of 9 comparable metrics.

INVA delivers a 46.5% return on equity — every $100 of shareholder capital generates $46 in annual profit, vs $-4 for IINN. ALKS carries lower financial leverage with a 0.04x debt-to-equity ratio, signaling a more conservative balance sheet compared to IINN's 0.58x. On the Piotroski fundamental quality scale (0–9), ALKS scores 7/9 vs IINN's 1/9, reflecting strong financial health.

MetricIINN logoIINNInspira Technolog…DBVT logoDBVTDBV Technologies …AVAV logoAVAVAeroVironment, In…ALKS logoALKSAlkermes plcINVA logoINVAInnoviva, Inc.
ROE (TTM)Return on equity-3.7%-130.2%-6.4%+8.8%+46.5%
ROA (TTM)Return on assets-2.8%-89.0%-5.0%+5.4%+32.4%
ROICReturn on invested capital+0.5%+3.6%+18.9%+14.2%
ROCEReturn on capital employed+0.2%-145.7%+4.5%+14.2%+12.4%
Piotroski ScoreFundamental quality 0–914375
Debt / EquityFinancial leverage0.58x0.13x0.07x0.04x0.23x
Net DebtTotal debt minus cash-$3M-$172M$23M-$1.0B-$282M
Cash & Equiv.Liquid assets$5M$194M$41M$1.1B$551M
Total DebtShort + long-term debt$3M$22M$64M$70M$269M
Interest CoverageEBIT ÷ Interest expense-189.82x-5.99x32.30x63.45x
ALKS leads this category, winning 5 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

INVA leads this category, winning 3 of 6 comparable metrics.

A $10,000 investment in INVA five years ago would be worth $19,437 today (with dividends reinvested), compared to $947 for IINN. Over the past 12 months, DBVT leads with a +110.4% total return vs IINN's -16.3%. The 3-year compound annual growth rate (CAGR) favors INVA at 25.0% vs IINN's -31.8% — a key indicator of consistent wealth creation.

MetricIINN logoIINNInspira Technolog…DBVT logoDBVTDBV Technologies …AVAV logoAVAVAeroVironment, In…ALKS logoALKSAlkermes plcINVA logoINVAInnoviva, Inc.
YTD ReturnYear-to-date-51.1%+4.9%-34.4%+25.3%+14.7%
1-Year ReturnPast 12 months-16.3%+110.4%+5.1%+16.5%+21.7%
3-Year ReturnCumulative with dividends-68.3%+19.7%+63.1%+14.5%+95.2%
5-Year ReturnCumulative with dividends-90.5%-69.1%+53.7%+60.9%+94.4%
10-Year ReturnCumulative with dividends-90.5%-87.0%+498.3%-11.0%+94.9%
CAGR (3Y)Annualised 3-year return-31.8%+6.2%+17.7%+4.6%+25.0%
INVA leads this category, winning 3 of 6 comparable metrics.

Risk & Volatility

Evenly matched — ALKS and INVA each lead in 1 of 2 comparable metrics.

INVA is the less volatile stock with a 0.13 beta — it tends to amplify market swings less than AVAV's 1.57 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. ALKS currently trades 96.7% from its 52-week high vs IINN's 27.3% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricIINN logoIINNInspira Technolog…DBVT logoDBVTDBV Technologies …AVAV logoAVAVAeroVironment, In…ALKS logoALKSAlkermes plcINVA logoINVAInnoviva, Inc.
Beta (5Y)Sensitivity to S&P 5001.52x1.26x1.57x1.06x0.13x
52-Week HighHighest price in past year$1.65$26.18$417.86$36.60$25.15
52-Week LowLowest price in past year$0.34$7.53$155.69$25.17$16.52
% of 52W HighCurrent price vs 52-week peak+27.3%+76.3%+40.2%+96.7%+90.7%
RSI (14)Momentum oscillator 0–10040.948.139.860.239.9
Avg Volume (50D)Average daily shares traded292K252K1.7M2.3M621K
Evenly matched — ALKS and INVA each lead in 1 of 2 comparable metrics.

Analyst Outlook

Insufficient data to determine a leader in this category.

Analyst consensus: DBVT as "Buy", AVAV as "Buy", ALKS as "Buy", INVA as "Buy". Consensus price targets imply 131.8% upside for DBVT (target: $46) vs 24.3% for ALKS (target: $44).

MetricIINN logoIINNInspira Technolog…DBVT logoDBVTDBV Technologies …AVAV logoAVAVAeroVironment, In…ALKS logoALKSAlkermes plcINVA logoINVAInnoviva, Inc.
Analyst RatingConsensus buy/hold/sellBuyBuyBuyBuy
Price TargetConsensus 12-month target$46.33$343.60$44.00$37.67
# AnalystsCovering analysts15282810
Dividend YieldAnnual dividend ÷ price
Dividend StreakConsecutive years of raises000
Dividend / ShareAnnual DPS
Buyback YieldShare repurchases ÷ mkt cap0.0%0.0%0.0%+0.5%+0.2%
Insufficient data to determine a leader in this category.
Key Takeaway

INVA leads in 3 of 6 categories (Income & Cash Flow, Valuation Metrics). ALKS leads in 1 (Profitability & Efficiency). 1 tied.

Best OverallInnoviva, Inc. (INVA)Leads 3 of 6 categories
Loading custom metrics...

IINN vs DBVT vs AVAV vs ALKS vs INVA: Key Questions Answered

10 questions · data-driven answers · updated daily

01

Is IINN or DBVT or AVAV or ALKS or INVA a better buy right now?

For growth investors, Innoviva, Inc.

(INVA) is the stronger pick with 18. 5% revenue growth year-over-year, versus -5. 2% for Alkermes plc (ALKS). Innoviva, Inc. (INVA) offers the better valuation at 6. 9x trailing P/E (11. 9x forward), making it the more compelling value choice. Analysts rate DBV Technologies S. A. (DBVT) a "Buy" — based on 15 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — IINN or DBVT or AVAV or ALKS or INVA?

On trailing P/E, Innoviva, Inc.

(INVA) is the cheapest at 6. 9x versus AeroVironment, Inc. at 108. 5x. On forward P/E, Innoviva, Inc. is actually cheaper at 11. 9x.

03

Which is the better long-term investment — IINN or DBVT or AVAV or ALKS or INVA?

Over the past 5 years, Innoviva, Inc.

(INVA) delivered a total return of +94. 4%, compared to -90. 5% for Inspira Technologies Oxy B. H. N. Ltd. (IINN). Over 10 years, the gap is even starker: AVAV returned +498. 3% versus IINN's -90. 5%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — IINN or DBVT or AVAV or ALKS or INVA?

By beta (market sensitivity over 5 years), Innoviva, Inc.

(INVA) is the lower-risk stock at 0. 13β versus AeroVironment, Inc. 's 1. 57β — meaning AVAV is approximately 1141% more volatile than INVA relative to the S&P 500. On balance sheet safety, Alkermes plc (ALKS) carries a lower debt/equity ratio of 4% versus 58% for Inspira Technologies Oxy B. H. N. Ltd. — giving it more financial flexibility in a downturn.

05

Which is growing faster — IINN or DBVT or AVAV or ALKS or INVA?

By revenue growth (latest reported year), Innoviva, Inc.

(INVA) is pulling ahead at 18. 5% versus -5. 2% for Alkermes plc (ALKS). On earnings-per-share growth, the picture is similar: Innoviva, Inc. grew EPS 816. 7% year-over-year, compared to -347. 5% for DBV Technologies S. A.. Over a 3-year CAGR, AVAV leads at 22. 6% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — IINN or DBVT or AVAV or ALKS or INVA?

Innoviva, Inc.

(INVA) is the more profitable company, earning 63. 8% net margin versus -43. 7% for Inspira Technologies Oxy B. H. N. Ltd. — meaning it keeps 63. 8% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: IINN leads at 45. 1% versus 0. 0% for DBVT. At the gross margin level — before operating expenses — ALKS leads at 86. 7%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is IINN or DBVT or AVAV or ALKS or INVA more undervalued right now?

On forward earnings alone, Innoviva, Inc.

(INVA) trades at 11. 9x forward P/E versus 58. 4x for AeroVironment, Inc. — 46. 5x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for DBVT: 131. 8% to $46. 33.

08

Which pays a better dividend — IINN or DBVT or AVAV or ALKS or INVA?

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

09

Is IINN or DBVT or AVAV or ALKS or INVA better for a retirement portfolio?

For long-horizon retirement investors, Innoviva, Inc.

(INVA) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 13)). Inspira Technologies Oxy B. H. N. Ltd. (IINN) carries a higher beta of 1. 52 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (INVA: +94. 9%, IINN: -90. 5%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between IINN and DBVT and AVAV and ALKS and INVA?

These companies operate in different sectors (IINN (Healthcare) and DBVT (Healthcare) and AVAV (Industrials) and ALKS (Healthcare) and INVA (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: IINN is a small-cap quality compounder stock; DBVT is a mega-cap quality compounder stock; AVAV is a small-cap quality compounder stock; ALKS is a small-cap quality compounder stock; INVA is a small-cap high-growth stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.

Stocks Like

IINN

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
Run This Screen
Stocks Like

DBVT

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
Run This Screen
Stocks Like

AVAV

High-Growth Disruptor

  • Sector: Industrials
  • Market Cap > $100B
  • Revenue Growth > 71%
  • Gross Margin > 13%
Run This Screen
Stocks Like

ALKS

High-Growth Disruptor

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 14%
  • Net Margin > 5%
Run This Screen
Stocks Like

INVA

Quality Mega-Cap Compounder

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Net Margin > 71%
Run This Screen

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.